What it's for (Indications)
- Acetylsalicylic acid (ASA), commonly known as aspirin, is a versatile non-steroidal anti-inflammatory drug (NSAID) with a broad spectrum of therapeutic applications.
- It is widely indicated for its analgesic, antipyretic, anti-inflammatory, and antiplatelet properties.
- For pain management, ASA effectively alleviates mild to moderate pain, including headaches, muscle aches, dental pain, menstrual cramps (dysmenorrhea), and general body aches.
- As an antipyretic, it is used to reduce fever associated with various conditions.
- Its anti-inflammatory actions are beneficial in managing inflammatory conditions such as rheumatoid arthritis, osteoarthritis, and other rheumatic diseases, where it helps reduce swelling, pain, and stiffness.
- Beyond these uses, ASA is crucially indicated for its antiplatelet effects, playing a vital role in cardiovascular disease prevention.
- It is prescribed for the primary and secondary prevention of myocardial infarction (heart attack), ischemic stroke, and transient ischemic attacks (TIAs).
- It is also used in the management of unstable angina, following percutaneous coronary intervention (PCI) with stent placement, and in other thrombotic conditions where inhibition of platelet aggregation is necessary.
- Additionally, ASA finds specific uses in conditions like Kawasaki disease and pericarditis, where its anti-inflammatory properties are leveraged.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | The dosage of acetylsalicylic acid (ASA) varies significantly based on its intended therapeutic effect, patient age, and clinical condition. For its analgesic and antipyretic actions, typical adult doses range from 325 mg to 650 mg taken orally every 4 to 6 hours as needed, with a maximum daily dose generally not exceeding 4 grams. For anti-inflammatory purposes, such as in the management of arthritis, higher doses are often required, typically ranging from 2.4 grams to 4 grams per day, administered in divided doses. These higher doses are carefully titrated and monitored due to increased risk of side effects. For its critical antiplatelet effect in cardiovascular prevention, much lower doses are utilized, commonly ranging from 75 mg to 325 mg taken once daily. Low-dose aspirin (e.g., 81 mg or 162 mg) is frequently prescribed for both primary and secondary prevention of thrombotic events. Enteric-coated formulations are often preferred for long-term low-dose regimens to minimize gastrointestinal irritation, though their absorption can be less predictable. It is imperative that dosage regimens for chronic conditions, particularly for cardiovascular prevention, be determined and regularly reviewed by a healthcare professional. Pediatric dosing, especially for conditions like Kawasaki disease, is weight-based and distinct from adult recommendations, and the use of aspirin in children and adolescents requires extreme caution due to the risk of Reye's syndrome. |
Safety & Warnings
Common Side Effects
- Acetylsalicylic acid (ASA) can elicit a range of side effects, varying in severity and frequency based on dose, duration of therapy, and individual patient factors.
- Common adverse reactions primarily involve the gastrointestinal (GI) system and include dyspepsia, heartburn, nausea, vomiting, and abdominal pain.
- More serious GI complications, such as gastritis, gastric or duodenal ulceration, and significant GI bleeding or perforation, are well-documented, with the risk increasing with higher doses, prolonged use, concurrent alcohol consumption, or concomitant use of other NSAIDs or anticoagulants.
- Hematologic side effects include an increased risk of bleeding, prolonged bleeding time, and, rarely, thrombocytopenia.
- Hypersensitivity reactions, ranging from urticaria (hives) and rash to severe manifestations like angioedema and bronchospasm (especially in patients with aspirin-exacerbated respiratory disease, AERD, or aspirin-induced asthma), can occur and may be life-threatening.
- Central nervous system effects, particularly with higher doses or chronic use, can manifest as tinnitus (ringing in the ears), hearing impairment, dizziness, and headache, indicative of salicylism.
- Renal dysfunction, including acute kidney injury, can occur, particularly in patients with pre-existing renal impairment, dehydration, or concurrent use of nephrotoxic agents.
- Hepatic impairment, although rare, has been reported.
- In children and adolescents recovering from viral infections, the use of aspirin is strongly associated with the development of Reye's syndrome, a rare but severe and potentially fatal condition involving acute encephalopathy and fatty liver degeneration.
Serious Warnings
- Black Box Warning: **Serious Warnings** While acetylsalicylic acid (ASA) does not carry a formal U.S. Food and Drug Administration (FDA) boxed warning, it is associated with several critical and potentially life-threatening risks that warrant specific emphasis. Healthcare professionals and patients must be fully aware of these serious warnings. 1. **Reye's Syndrome Risk:** The use of acetylsalicylic acid in children and adolescents, particularly those recovering from or experiencing viral infections such as influenza or chickenpox, is strongly associated with the development of Reye's syndrome. This is a rare but extremely serious condition characterized by acute encephalopathy and fatty liver degeneration, which can lead to permanent brain damage or death. Consequently, ASA should be avoided in these patient populations unless specifically directed by a healthcare provider for conditions where the benefits clearly outweigh this significant risk (e.g., Kawasaki disease). Alternative antipyretics and analgesics are recommended for viral illnesses in children and adolescents. 2. **Gastrointestinal (GI) Bleeding and Ulceration Risk:** Acetylsalicylic acid can cause serious, potentially fatal, gastrointestinal adverse events, including bleeding, ulceration, and perforation of the stomach or intestine. These events can occur at any time during treatment, often without warning symptoms. The risk is significantly increased in elderly patients, those with a history of peptic ulcer disease or gastrointestinal bleeding, individuals who consume substantial amounts of alcohol, and patients concurrently taking anticoagulants (e.g., warfarin), corticosteroids, or other non-steroidal anti-inflammatory drugs (NSAIDs). Patients should be advised to be vigilant for signs of GI bleeding, such as black, tarry stools, or vomiting blood, and to seek immediate medical attention if these symptoms occur. 3. **Bleeding Risk:** Beyond localized GI bleeding, acetylsalicylic acid, due to its irreversible antiplatelet effects, significantly increases the risk of general bleeding. This risk is particularly relevant in patients undergoing surgical procedures, including dental extractions, and those with pre-existing hemorrhagic disorders. Healthcare providers should consider discontinuing ASA therapy prior to elective surgery based on the individual patient's risk-benefit profile and the specific type of procedure. Patients should inform their healthcare provider and dentist about their ASA use. 4. **Hypersensitivity Reactions / Aspirin-Exacerbated Respiratory Disease (AERD):** Severe and potentially life-threatening hypersensitivity reactions, including anaphylaxis, angioedema, and severe bronchospasm (often referred to as aspirin-induced asthma or AERD), can occur in susceptible individuals. This risk is elevated in patients with a history of asthma, nasal polyps, or chronic urticaria. Patients experiencing difficulty breathing, swelling of the face or throat, or severe rash should seek emergency medical care immediately.
- Acetylsalicylic acid (ASA) carries several critical warnings that necessitate careful consideration before and during treatment.
- A paramount concern, especially in pediatric populations, is the strong association with **Reye's Syndrome**, a rare but severe and often fatal condition characterized by acute encephalopathy and fatty liver degeneration.
- Therefore, ASA should not be used in children and adolescents for viral infections, particularly influenza or chickenpox, due to this significant risk.
- Another major warning pertains to the risk of **Gastrointestinal (GI) Bleeding and Ulceration**.
- ASA, especially at higher doses or with chronic use, can cause serious GI adverse events, including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal.
- This risk is amplified in elderly patients, those with a history of peptic ulcer disease or GI bleeding, concurrent use of anticoagulants, corticosteroids, or other NSAIDs, and individuals who consume alcohol.
- Patients should be advised to report any signs of GI bleeding immediately.
- The antiplatelet action of ASA increases the overall **Bleeding Risk**, which can be clinically significant during surgical procedures, dental extractions, or in patients with pre-existing bleeding disorders.
- Discontinuation of ASA before elective surgery is often recommended, based on clinical judgment.
- **Hypersensitivity Reactions**, including anaphylaxis, angioedema, and severe bronchospasm (aspirin-induced asthma), can occur, particularly in individuals with asthma, nasal polyps, or a history of allergic reactions to NSAIDs.
- Patients should be counselled on these potential adverse events and seek immediate medical attention if they occur.
- Caution is advised in patients with impaired **Renal or Hepatic Function**, as ASA metabolism and excretion may be affected, leading to accumulation and increased toxicity.
- ASA should be avoided in the third trimester of **Pregnancy** due to risks of premature closure of the fetal ductus arteriosus, pulmonary hypertension in the newborn, and increased maternal/fetal bleeding.
- Concomitant use with alcohol can augment the risk of GI bleeding, and interactions with other medications (e.
- g.
- , anticoagulants, other NSAIDs, methotrexate, diuretics, ACE inhibitors) can alter efficacy or increase toxicity.
- Patients experiencing tinnitus or hearing loss may be exhibiting signs of salicylism and should seek medical advice.
How it Works (Mechanism of Action)
Acetylsalicylic acid (ASA) exerts its diverse therapeutic effects primarily through the irreversible inhibition of cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2. This inhibition leads to a profound reduction in the synthesis of prostaglandins, thromboxanes, and prostacyclin, which are lipid mediators derived from arachidonic acid and play critical roles in various physiological and pathophysiological processes.
The analgesic and antipyretic properties of ASA stem from its inhibition of prostaglandin synthesis, particularly in the central nervous system (hypothalamus for fever) and at peripheral sites of pain and inflammation. By reducing prostaglandin levels, ASA mitigates the sensitization of peripheral nociceptors and lowers the hypothalamic set point for body temperature.
The anti-inflammatory action is also mediated by the reduction of prostaglandin synthesis, which otherwise contributes to vasodilation, increased vascular permeability, and pain in inflammatory processes.
Crucially, ASA's antiplatelet effect is a result of its irreversible acetylation of COX-1 within platelets. Platelets, being anucleated, cannot synthesize new COX-1 enzyme, meaning the antiplatelet effect lasts for the entire lifespan of the platelet, approximately 7 to 10 days. This inhibition prevents the formation of thromboxane A2 (TXA2), a potent vasoconstrictor and inducer of platelet aggregation. By inhibiting TXA2 production, ASA effectively reduces the ability of platelets to clump together and form blood clots, thus preventing thrombotic events in cardiovascular diseases. This irreversible binding to COX-1 is a key distinguishing feature of ASA compared to other NSAIDs, which typically cause reversible inhibition. High doses of ASA may also exhibit some reversible COX-2 inhibition, contributing to anti-inflammatory effects.
Commercial Brands (Alternatives)
No other brands found for this formula.